UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005764 |
|---|---|
| Receipt number | R000006511 |
| Scientific Title | A Phase2 Study of Platinum Doublet and Bevacizumab followed by Bevacizumab and Pemetrexed maintenance for Non-squarmous Non Small Cell Lung Cancer Patients |
| Date of disclosure of the study information | 2011/06/16 |
| Last modified on | 2014/06/13 09:10:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/13 11:53:42 | ||
| 2 | Update | 2011/06/13 11:54:51 | Recruitment status |
|
| 3 | Update | 2012/06/14 16:23:13 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 4 | Update | 2014/06/13 09:10:45 | TEL Address Address TEL |
